Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome

Razelle Kurzrock, Hagop M. Kantarjian, Michelle A. Blascovich, Cindy Bucher, Srdan Verstovsek, John J. Wright, Susan R. Pilat, Jorge E. Cortes, Elihu H. Estey, Francis J. Giles, Miloslav Beran, Said M. Sebti

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of alternate-week administration of tipifarnib in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences